Numerous studies have shown that IL-13 is a central regulator of T-helper type 2 (Th2)-dominated disorders such as asthma, and some studies have suggested that IL-13 blockade prevents allergen-induced airway inflammation [67]. The gene discussed is IL13; the disease is asthma.